Literature DB >> 21316711

Motor and sensory conduction failure in overlap of Guillain-Barré and Miller Fisher syndrome: two simultaneous cases.

Yusuf A Rajabally1, Ghaniah Hassan-Smith, Francesca Notturno, Penelope J Eames, Thomas Hayton, Margherita Capasso, Antonino Uncini.   

Abstract

We report 2 patients diagnosed simultaneously with an overlap of Guillain-Barré syndrome (GBS) and Miller Fisher syndrome (MFS), who had anti-GT1a, anti-GQ1b, anti-GD1a and anti-GD1b antibodies. There was no identifiable specific preceding infection. Both patients presented with upper and lower limb paresthesias and severe weakness, bulbar and facial weakness, ophthalmoparesis and areflexia. In one, electrophysiology demonstrated multifocal conduction blocks (CBs) and mild motor conduction velocity slowing in intermediate segments and absent sensory nerve action potentials (SNAPs). The patient improved rapidly and fully recovered within 18 days from onset. CBs resolved, distal compound muscle action potential (CMAP) amplitudes increased and SNAPs normalized on subsequent testing. In the other patient, initial studies showed low/normal CMAPs, with absent SNAPs, without demyelinating features. This patient fully recovered within 21 days from onset. CMAPs markedly increased, SNAPs improved marginally. These 2 patients exhibited features indicative of the pathophysiological mechanism of conduction failure in motor and sensory fibers. This phenomenon relates to rapidly resolving CBs possibly induced by the transitory and limited attack of antiganglioside antibodies at the axolemma of the nodes of Ranvier not progressing to axonal degeneration. These cases widen the range of GBS subtypes in which reversible conduction failure has been described, to include overlap syndromes with MFS. The factors determining the electrophysiology, as well as the rate, degree and quality of recovery in GBS subtypes remain uncertain at the present time.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21316711     DOI: 10.1016/j.jns.2011.01.019

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  Atypical Variant of Guillain Barre Syndrome in a Patient with COVID-19.

Authors:  Megan M Lowery; Muhammad Taimur Malik; Joseph Seemiller; Cynthia S Tsai
Journal:  J Crit Care Med (Targu Mures)       Date:  2020-11-07

2.  Integrated Chinese and Western Medicine for Acute Guillain-barré Syndrome Treatment.

Authors:  Liu Yang; Xiumin Zhao
Journal:  Transl Neurosci       Date:  2020-02-29       Impact factor: 1.757

3.  Atypical Electrophysiological Findings in a Patient with Acute Motor and Sensory Axonal Neuropathy.

Authors:  Viviana Versace; Stefania Campostrini; Frediano Tezzon; Sara Martignago; Markus Kofler; Leopold Saltuari; Luca Sebastianelli; Raffaele Nardone
Journal:  Front Neurol       Date:  2017-11-08       Impact factor: 4.003

4.  Miller Fisher syndrome, Bickerstaff brainstem encephalitis and Guillain-Barré syndrome overlap with persistent non-demyelinating conduction blocks: a case report.

Authors:  Angela Puma; Jeanne Benoit; Sabrina Sacconi; Antonino Uncini
Journal:  BMC Neurol       Date:  2018-07-21       Impact factor: 2.474

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.